Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma
Cesarman E, Dalla-Favera R, Bentley D, Groudine M. 1987. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 238:1272-1275.
Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells
Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. 1982. Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 79:7824-7827
Characterization of the human immunoglobulin kappa gene 3′ enhancer: Functional importance of three motifs that demonstrate B-cell-specific in vivo footprints
Judde JG and Max EE. 1992. Characterization of the human immunoglobulin kappa gene 3′ enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints. Mol Cell Biol 12:5206-5216.
Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells
Madisen L, Groudine M. 1994. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev 8:2212-2226.
B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu)
Palomo C, Zou X, Nicholson IC. 1999. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu). Cancer Res 59:5625-5628.
The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles
Spencer CA, LeStrange RC, Novak U, Hayward WS, Groudine M. 1990. The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles. Genes Develop 4:75-88.
Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells
Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P. 1982. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA 79:7837-7841.
Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells
Taub R, Moulding C, Battey J, Murphy W, Vasicek T, Lenoir GM, Leder P. 1984. Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells. Cell 36:339-348.
Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children
Wilda M, Bruch J, Harder L, Rawer D, Reiter A, Borkhardt A, Woessmann W. 2004. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children. Leukemia 18:584-588.
Phosphorylation-dependent binding of a 138-kDa myc intron factor to a regulatory element in the first intron of the c-myc gene
Zajac-Kaye M, Levens D. 1990. Phosphorylation-dependent binding of a 138-kDa myc intron factor to a regulatory element in the first intron of the c-myc gene. J Biol Chem 15:4547-4551.
A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein
Zajac-Kaye M, Gelmann EP, Levens D. 1988. A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein. Science 24:1776-1780.
